BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1018810)

  • 1. [Immunotherapy with BCG in pulmonary tumors].
    Tanzj PL
    Minerva Med; 1976 Dec; 67(63):4167-72. PubMed ID: 1018810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current trends in immunotherapy of tumors of the lung].
    Crispano G; Toglia V; Tranchese D; Schettini R
    Arch Monaldi; 1983; 38(1-2):41-52. PubMed ID: 6675558
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunotherapy of carcinoma of the lung].
    Sega E; Mineo TC; Rea SR; Sega FM; Ricci C
    Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751
    [No Abstract]   [Full Text] [Related]  

  • 4. [BCG vaccine immunotherapy after radical operations for lung cancer].
    Repin IuM
    Vestn Khir Im I I Grek; 1992; 149(7-8):11-6. PubMed ID: 1341347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy of lung cancer].
    Jassem J; Jassem E
    Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical results with immunochemotherapy in 40 cases of advanced tumour.
    Narcisi M
    Panminerva Med; 1975; 17(5-6):208-10. PubMed ID: 1161322
    [No Abstract]   [Full Text] [Related]  

  • 7. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of lung cancer patients treated with BCG and/or a soluble BCG fraction (F70) after surgery, radiotherapy and chemotherapy.
    Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P; Madźarova S; Spassova M
    Neoplasma; 1980; 27(1):83-94. PubMed ID: 7374861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
    Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG immunostimulation in primary pulmonary cancer (a clinical, immunological and radiological study).
    Dénes L; Büttner K; Galambos G; Krasznai G
    Dev Biol Stand; 1986; 58 ( Pt A)():425-32. PubMed ID: 3297874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantoux, DNCB test, peripheral blood phagocyte activity and serum immunoglobulin levels in BCG vaccination treatment of lung tumor patients.
    Prugberger E; Hegyi P; Drinóczy M
    Dev Biol Stand; 1986; 58 ( Pt A)():395-9. PubMed ID: 3596045
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reevaluation of immunopotentiation therapy for cancer].
    Toyoshima K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):817-23. PubMed ID: 10897207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of lung cancer: a review.
    Takita H
    Int Adv Surg Oncol; 1983; 6():229-56. PubMed ID: 6192089
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy as related to lung cancer: a review.
    Hersh EM; Mavligit GM; Gutterman JU
    Semin Oncol; 1974 Sep; 1(3):273-8. PubMed ID: 4620434
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of advanced primary lung cancer, particularly immunotherapy with BCG-CWS (author's transl)].
    Ohta M; Iida A; Ueda H; Yasumoto K; Manabe H
    Kyobu Geka; 1977 Jul; 30(7):581-5. PubMed ID: 904107
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic capacity of cancer patients and BCG-CSW immunotherapy].
    Yasumoto K; Manabe H; Yanagawa E; Nagano S; Ueda H
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):449-51. PubMed ID: 381535
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary results of nonspecific immunotherapy for lung cancer.
    Israel L
    Cancer Chemother Rep 3; 1973 Mar; 4(2):283-6. PubMed ID: 4729331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Activation of natural antitumor resistance in cancer patients during a delayed hypersensitivity reaction].
    Gordienko SM; Novichev AP; Avdiunicheva OE; Churilova LA
    Vopr Onkol; 1988; 34(5):572-6. PubMed ID: 3381499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunochemotherapy of lung neoplasms].
    Ikegami H
    Nihon Rinsho; 1980 Jul; 38(7):2691-700. PubMed ID: 6257950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.